Your browser doesn't support javascript.
loading
Corrigendum: Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms.
Sanchez, Belkys C; Heckmann, Emmaline R; Green, Sabrina I; Clark, Justin R; Kaplan, Heidi B; Ramig, Robert F; Muldrew, Kenneth L; Hines-Munson, Casey; Skelton, Felicia; Trautner, Barbara W; Maresso, Anthony W.
Afiliação
  • Sanchez BC; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
  • Heckmann ER; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
  • Green SI; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
  • Clark JR; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
  • Kaplan HB; Department of Microbiology and Molecular Genetics, McGovern Medical School, UTHealth Houston, Houston, TX, United States.
  • Ramig RF; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
  • Muldrew KL; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
  • Hines-Munson C; Pathology and Laboratory Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, United States.
  • Skelton F; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, United States.
  • Trautner BW; Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States.
  • Maresso AW; Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States.
Front Microbiol ; 13: 953136, 2022.
Article em En | MEDLINE | ID: mdl-36016800
ABSTRACT
[This corrects the article DOI 10.3389/fmicb.2022.796132.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos